Prothrombin Complex is named as an intervention in 4 current clinical trials in our South Korea, China and Austria registers. 3 are recruiting patients now. The most common phase is Phase 4. The sponsor with the most trials is Konkuk University Medical Center (2). The most-studied condition is Traumatic Bleeding.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Coagulation in Cirrhosis
NCT05667805 · ClinicalTrials.gov ↗ · Liver Cirrhosis
|
Phase 4 | Recruiting | Medical University of Vienna | Austria |
|
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
NCT06144125 · ClinicalTrials.gov ↗ · Cardiac Valve Disease
|
Phase 4 | Recruiting | Konkuk University Medical Center | South Korea |
|
Liberal or Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma
NCT06627218 · ClinicalTrials.gov ↗ · Traumatic Bleeding
|
Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | China |
|
Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery
NCT06144112 · ClinicalTrials.gov ↗ · Liver Diseases
|
Phase 4 | Not yet open | Konkuk University Medical Center | South Korea |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Konkuk University Medical Center | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Medical University of Vienna | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in South Korea | 2 | 1 |
| Clinical trials in China | 1 | 1 |
| Clinical trials in Austria | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
4 current trials in our South Korea, China and Austria registers name Prothrombin Complex as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 4 trials are recruiting: 1 with sites in South Korea, 1 with sites in China and 1 with sites in Austria. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Konkuk University Medical Center (2), Second Affiliated Hospital, Zhejiang University, School of Medicine (1) and Medical University of Vienna (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Prothrombin Complex works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Prothrombin Complex works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Prothrombin Complex (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.